200
Participants
Start Date
January 26, 2018
Primary Completion Date
June 6, 2024
Study Completion Date
June 30, 2026
Treatment recommendation
Depending on the results from the participant's archival tissue, a panel of Johns Hopkins investigators will meet to interpret the molecular and genetic profiling results in order to identify any actionable mutations to provide a personalized treatment recommendation for the patient.
Allegheny Health Network Cancer Institute, Pittsburgh
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Collaborators (2)
Foundation Medicine
INDUSTRY
Avon Foundation
OTHER
Biocept, Inc.
INDUSTRY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER